"Eich" at 12:30 I guess he felt he needed to clarify the 10:00 AM post (LOL!)
An outright lie! If one bioreactor can produce 20,000 doses, two bioreactors can produce 40,000, three can produce 60,000... (can you continue this simple arithmetic progression???)
What the hell do you think they're using to reverse gangrene and forestall incipient amputation? How about dozens of other top notch institutions doing clinical trials and getting good results? Your lies are over the top (nothing new in that regard ...).
Now, to the question of why we're dropping. First, let's recognize that the market is not rational in the short term, so applying rational analysis has to be done with that in mind. It may be that there's no reason at all!
On the other hand, there are factors that make Pluristem vulnerable. It's a small company, it's in Israel (less awareness by the market), manipulation by financial interests, tough biotech market, EOY selling, etc.. I would dismiss any wild speculation as.... wild speculation. What is concrete is the excellent results as seen by Dr.Landis and others in the clinic (vs unsupported assertions by an anonymous voice from the ether: "Eich" ... which is more credible?)